These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Does the pro-hypertensive effect of cyclooxygenase-2 inhibitors account for the increased risk in cardiovascular disease? Messerli FH; Sichrovsky T Am J Cardiol; 2005 Sep; 96(6):872-3. PubMed ID: 16169380 [No Abstract] [Full Text] [Related]
6. Blood pressure control and rates of edema following the administration of the cyclooxygenase-2 specific inhibitors celecoxib versus rofecoxib in patients with systemic hypertension and osteoarthritis. Weaver A; Alderman M; Sperling R Am J Cardiol; 2003 May; 91(10):1291-2. PubMed ID: 12745131 [No Abstract] [Full Text] [Related]
12. Are selective COX 2 inhibitors superior to traditional NSAIDs? Both the CLASS and VIGOR trials support the COX 2 hypothesis. Stover RR BMJ; 2002 Jul; 325(7356):161; author reply 161. PubMed ID: 12134855 [No Abstract] [Full Text] [Related]
13. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart]. MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204 [No Abstract] [Full Text] [Related]
14. Are selective COX 2 inhibitors superior to traditional NSAIDs? Rofecoxib did not provide unequivocal benefit over traditional NSAIDs. Budenholzer BR BMJ; 2002 Jul; 325(7356):161; author reply 161. PubMed ID: 12130617 [No Abstract] [Full Text] [Related]
17. Celecoxib, rofecoxib, and acute temporary visual impairment. Coulter DM; Clark DW; Savage RL BMJ; 2003 Nov; 327(7425):1214-5. PubMed ID: 14630760 [No Abstract] [Full Text] [Related]
18. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs]. Houben JJ; Liem B Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2338. PubMed ID: 10589225 [No Abstract] [Full Text] [Related]
19. Summaries for patients. Cyclooxygenase-2 inhibitors and heart attacks: varying effects? Ann Intern Med; 2005 Feb; 142(3):I21. PubMed ID: 15684199 [No Abstract] [Full Text] [Related]
20. COX-2 inhibitors and cardiovascular toxicity: a class effect? Laible B S D J Med; 2005 Mar; 58(3):93-4. PubMed ID: 15794479 [No Abstract] [Full Text] [Related] [Next] [New Search]